Top segments and regional performance

Last year, the company generated ‪142.78 B‬ INR, the most of which — ‪142.78 B‬ INR — came from its top-performing segment, Pharmaceuticals, compared to ‪122.07 B‬ INR the previous year. The greatest contribution came from India, which accounted for ‪122.16 B‬ INR last year, with ‪106.75 B‬ INR the year before.